Capital Impact Advisors, LLC Exact Sciences Corp Transaction History

Capital Impact Advisors, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 16, 2024	SELL	$41.33 - $74.26 $359,860 - $646,581	-8,707 Reduced 40.92%	12,572 $531,000
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $708,157 - $928,395	12,585 Added 144.76%	21,279 $1.47 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $270,731 - $347,100	4,584 Added 111.53%	8,694 $643,000
Q2 2023 Aug 14, 2023	SELL	$62.68 - $95.05 $47,448 - $71,952	-757 Reduced 15.55%	4,110 $385,000
Q1 2023 May 23, 2023	SELL	$47.19 - $70.77 $75,928 - $113,868	-1,609 Reduced 24.85%	4,867 $330,000
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $31,655 - $55,435	1,043 Added 19.2%	6,476 $320,000
Q3 2022 Nov 21, 2022	BUY	$31.97 - $49.37 $83,505 - $128,954	2,612 Added 92.59%	5,433 $201,000
Q2 2022 Aug 15, 2022	SELL	$35.61 - $76.23 $144,291 - $308,883	-4,052 Reduced 58.96%	2,821 $111,000
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $395,609 - $567,297	6,873 New	6,873 $481,000
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $971,500 - $1.35 Million	-13,400 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $3.07 Million - $4.22 Million	-33,988 Reduced 71.72%	13,400 $1.28 Million
Q2 2021 Aug 17, 2021	BUY	$93.66 - $139.27 $3.55 Million - $5.27 Million	37,854 Added 397.04%	47,388 $5.4 Million
Q1 2021 May 18, 2021	SELL	$116.57 - $155.01 $7.01 Million - $9.33 Million	-60,168 Reduced 86.32%	9,534 $1.26 Million
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $498,050 - $710,600	5,000 Added 7.73%	69,702 $9.24 Million
Q3 2020 Nov 13, 2020	BUY	$72.92 - $102.01 $4.72 Million - $6.6 Million	64,702 New	64,702 $6.6 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.